IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis.

Deng, Zhenzhen; Wang, Shengfeng; Wu, Cuifang; Wang, Chunjiang

Deng, Zhenzhen; Wang, Shengfeng; Wu, Cuifang; Wang, Chunjiang.

Afiliación

Deng Z; Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wang S; Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wu C; Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wang C; Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

Front Pharmacol ; 14: 1124628, 2023.

Article en En | MEDLINE | ID: mdl-37033665

Palabras clave

FAERS database; IL-17 inhibitors; drug safety; inflammatory bowel disease; pharmacovigilance

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google